Biogen

We’re thrilled to announce this year’s Golden Tickets winners: Arpelos Biosciences, Noara Therapeutics and Lyberna.    With our sponsorship of LabCentral, each of these early-stage biotech innovators receives $50,000 credit toward resources at LabCentral’s Cambridge site where they can continue breakthrough work and delve deep into creating cutting-edge technologies.    Congratulations to this year’s winners who are helping to make the future of science possible today. 

We’re attending the American Transplant Congress (ATC) to share new data on our investigational therapy designed to target CD-38 cells in antibody-mediated rejection (AMR) and microvascular inflammation (MVI).     Stop by booth #632 to learn more about our ongoing research and late-stage clinical trials for kidney transplant recipients diagnosed with AMR and MVI. Learn more: ow.ly/MNtN50ZcR2t

Today, we announced an agreement to acquire RayThera Inc. With this deal, we aim to add multiple immunology assets to our portfolio that will contribute to our long-term pipeline potential. Read more about this deal: ow.ly/ogXF50Ze1H3   #News

About 1 in 9 people age 65 and older have clinical Alzheimer’s dementia. That’s millions of patients, families, and caregivers who navigate this disease every day.    Learn how we’re turning awareness into action this Alzheimer's and Brain Awareness Month — because the people impacted by this disease can’t wait. Discover more of our work: ow.ly/npiT50ZcQRY   #ENDALZ

Adem Koksal, Ph.D., and cross‑functional teams across Biogen have spent years developing a scalable strategy to enable the transport of therapies across the blood-brain barrier. Their work seeks to address a complex scientific challenge with an engineering-driven approach.    The result: a differentiated and highly targeted delivery platform designed to potentially help therapies reach deeper regions of the brain, with the goal of improving safety and efficacy.    Learn more about this work: ow.ly/mgcY50ZcQ4V

What happens when something feels “off,” but finding the words feels impossible? Parents Magazine explores one of the biggest barriers in postpartum depression (PPD) care: starting the conversation. Learning the potential signs and symptoms of PPD, reducing stigma, and creating space for open conversations with healthcare providers, family, and friends can help mothers get support sooner. Sometimes raising a yellow flag can be the first step. Read more: ow.ly/QqWJ50Za9J9

Our biomarkers strategy is a central link between our understanding of disease biology and the signals that help translate science, track disease progression and generate data to help support well-informed R&D decision making.    Through a collaboration with Aitia, we’re using AI with the goal of better understanding target engagement and disease progression in neurodegenerative conditions like Huntington’s disease.    Read more about our approach to biomarkers: ow.ly/2ykR50Z9xi6

Biomarkers play a critical role across our pipeline, helping to guide decision making, focus resources, and accelerate research.    From neurology to rare diseases to immunology, our teams apply biomarker insights to help advance science for patients.    Learn more about this work: ow.ly/jr1v50Z8XFk

SLE is the most common form of lupus and can impact multiple organs and systems throughout the body. Our team is focused on advancing the understanding of lupus by studying its clinical and biological variability. See how we’re working toward potential new options to address the needs of this community: ow.ly/uMWo50Z7Q2i

This week we welcomed our 2026 class of Biogen summer interns!   Across the next twelve weeks, this group will bring incredible talent, curiosity, and perspective to teams throughout the company, representing a wide range of academic backgrounds, disciplines, and institutions across the country.   We’re excited to host several students returning for a second internship with us, continuing to build on the impact they’ve already made, while also welcoming interns for the first time at our West Coast Hub.   It’s a privilege to support and learn from a thoughtful, driven, and talented group of future leaders. We’re grateful they’ve chosen Biogen to be part of their journey.   Welcome to #TeamBiogen!